Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Endometrial Neoplasms and BRAF[original query] |
---|
Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes. Journal of cancer research and clinical oncology 2012 Mar 138 (3): 377-85. Wang Li-E, Ma Hongxia, Hale Katherine S, Yin Ming, Meyer Larissa A, Liu Hongliang, Li Jie, Lu Karen H, Hennessy Bryan T, Li Xuesong, Spitz Margaret R, Wei Qingyi, Mills Gordon |
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Mar 30 (8): 777-82. Janku Filip, Wheler Jennifer J, Westin Shannon N, Moulder Stacy L, Naing Aung, Tsimberidou Apostolia M, Fu Siqing, Falchook Gerald S, Hong David S, Garrido-Laguna Ignacio, Luthra Rajyalakshmi, Lee J Jack, Lu Karen H, Kurzrock Razel |
BRAF V600E Mutations in Endometrial Adenocarcinoma. Diagnostic molecular pathology : the American journal of surgical pathology, part B 2013 Mar 22 (1): 1. He M, Breese V, Hang S, Zhang C, Xiong J, Jackson C |
Molecular and clinical characteristics of MSH6 germline variants detected in colorectal cancer patients. Oncology reports 2013 Dec 30 (6): 2909-16. Terui Hiroko, Tachikawa Tetsuhiko, Kakuta Miho, Nishimura Yoji, Yatsuoka Toshimasa, Yamaguchi Kensei, Yura Kei, Akagi Kiwa |
Risk of secondary malignancy (including breast) in patients with mismatch-repair protein deficiency. The American journal of surgical pathology 2014 Nov 38 (11): 1494-500. Clay Michael R, Allison Kimberly H, Folkins Ann K, Longacre Teri |
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2015 Jun 28 (6): 836-44. Stelloo Ellen, Bosse Tjalling, Nout Remi A, MacKay Helen J, Church David N, Nijman Hans W, Leary Alexandra, Edmondson Richard J, Powell Melanie E, Crosbie Emma J, Kitchener Henry C, Mileshkin Linda, Pollock Pamela M, Smit Vincent T, Creutzberg Carien |
Germline mismatch repair gene variants analyzed by universal sequencing in Japanese cancer patients. Cancer medicine 2019 Aug . Kiyozumi Yoshimi, Matsubayashi Hiroyuki, Horiuchi Yasue, Higashigawa Satomi, Oishi Takuma, Abe Masato, Ohnami Sumiko, Urakami Kenichi, Nagashima Takeshi, Kusuhara Masatoshi, Miyake Hidehiko, Yamaguchi K |
Role of Tumor Mutation Burden Analysis in Detecting Lynch Syndrome in Precision Medicine: Analysis of 2,501 Japanese Cancer Patients. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2020 10 30 (1): 166-174. Kiyozumi Yoshimi, Matsubayashi Hiroyuki, Higashigawa Satomi, Horiuchi Yasue, Kado Nobuhiro, Hirashima Yasuyuki, Shiomi Akio, Oishi Takuma, Ohnami Sumiko, Ohshima Keiichi, Urakami Kenichi, Nagashima Takeshi, Yamaguchi K |
Microsatellite Instability Is Insufficiently Used as a Biomarker for Lynch Syndrome Testing in Clinical Practice. JCO precision oncology 2024 1 8 e2300332. Eirini Papadopoulou, George Rigas, Elena Fountzilas, Anastasios Boutis, Stylianos Giassas, Nikolaos Mitsimponas, Danai Daliani, Dimitrios C Ziogas, Michalis Liontos, Vasileios Ramfidis, Charalampos Christophilakis, Dimitris Matthaios, Theofanis Floros, Chrysiida Florou-Chatzigiannidou, Konstantinos Agiannitopoulos, Angeliki Meintani, Aikaterini Tsantikidi, Anastasia Katseli, Kevisa Potska, Georgios Tsaousis, Vasiliki Metaxa-Mariatou, George Nasioul |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: